How do I tell if TLX is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Telix Pharmaceuticals Limited American Depositary Shares (TLX) Stock

NASDAQ · TLX

Trade TLX

Fundamentals

Market cap

$3.74B

Price / Earnings ratio

-751.6x

Price / Sales ratio

7.0x

Price / Book ratio

11.2x

Dividend amount

$0.00

Dividend yield

0.00%

Source: third-party data provider, as of October 9, 2026

Compare with TLX

Technical indicators

RSI 14: 46.47
MACD 12/26/9: -0.19
EMA 9 of MACD: -0.12
MACD histogram: -0.07
SMA 50: $11.44; Price below SMA 50
EMA 50: $11.29; Price below EMA 50
SMA 200: $9.71; Price above SMA 200
EMA 200: $10.15; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of October 8, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 2 analysts

Strong Sell0

Sell0

Hold0

Buy2

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

No data available

Debt & Balance Sheet

No data available

Revenue to Profit

No data available

Earnings

No data available

Source: third-party data provider

About Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

SectorHealthcare

IndustryBiotechnology

Employees1,120

CEOMr. Raphael Ortiz L.L.B., M.B.A.

IPO DateNov 13, 2024

HeadquartersNorth Melbourne, VIC

Key Executives

Name	Title	Year Born
Mr. Darren Smith B.Bus., FCPA, M.B.A.	Group Chief Financial Officer	1965
Dr. Paul Schaffer	SVP of Research & Development	—
Mr. Craig Ulrick	Chief Information Officer	—
Ms. Kyahn Williamson B.A.	Senior Vice President of Corporate Communications & Investor Relations	—
Mr. Christian Krautkramer J.D.	Group General Counsel	—
Thomas Fromm	Vice President of Sales	—
Ms. Meredith Crowe BDES	Senior Vice President of Global People & Culture	—
Dr. Andreas Kluge M.D., Ph.D.	Chief Medical Advisor	1965
Ms. Odile Jaume M.B.A., M.Sc.	Advisor	—
Mr. Raphael Ortiz L.L.B., M.B.A.	Chief Executive Officer of Telix International	—

Stocks in the same sector

Vertex Pharmaceuticals

ABEO

Abeona Therapeutics Inc.

FAQ

Buying Telix Pharmaceuticals Limited American Depositary Shares (TLX) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and complete KYC.
Make a deposit.
Search for the code "TLX", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy TLX by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Telix Pharmaceuticals Limited American Depositary Shares from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Telix Pharmaceuticals Limited American Depositary Shares (TLX) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track TLX's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.

Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trading Lebih Cepat. Lebih Mudah. Lebih Cerdas.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Telix Pharmaceuticals Limited American Depositary Shares (TLX) Stock

Fundamentals

Compare with TLX

Recent news

Wall Street Analysts Believe Telix Pharmaceuticals Limited (TLX) Could Rally 83.42%: Here's is How to Trade

Wall Street Analysts Believe Telix Pharmaceuticals Limited (TLX) Could Rally 83.42%: Here's is How to Trade

Telix Beefs Up Radioisotopes Supply With $2.35 Billion Deal; Shares Crash

Telix Beefs Up Radioisotopes Supply With $2.35 Billion Deal; Shares Crash

Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion

Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion

TLX Stock Clocks 5% Gain This Week Ahead Of FDA Decision On Brain Cancer Imaging Agent

TLX Stock Clocks 5% Gain This Week Ahead Of FDA Decision On Brain Cancer Imaging Agent

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Wall Street Analysts Believe Telix Pharmaceuticals Limited (TLX) Could Rally 83.42%: Here's is How to Trade

Wall Street Analysts Believe Telix Pharmaceuticals Limited (TLX) Could Rally 83.42%: Here's is How to Trade

Telix Beefs Up Radioisotopes Supply With $2.35 Billion Deal; Shares Crash

Telix Beefs Up Radioisotopes Supply With $2.35 Billion Deal; Shares Crash

Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion

Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion

TLX Stock Clocks 5% Gain This Week Ahead Of FDA Decision On Brain Cancer Imaging Agent

TLX Stock Clocks 5% Gain This Week Ahead Of FDA Decision On Brain Cancer Imaging Agent

Telix Pharmaceuticals H1 Earnings Call Highlights

Telix Pharmaceuticals H1 Earnings Call Highlights

TLX Stock Surges Overnight After FDA Agrees To Review Brain Cancer Imaging Agent Application

TLX Stock Surges Overnight After FDA Agrees To Review Brain Cancer Imaging Agent Application

About Telix Pharmaceuticals Limited American Depositary Shares

Key Executives

Fundamentals

Valuation

Income Statement

Dividend

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trading Lebih Cepat. Lebih Mudah. Lebih Cerdas.

#ReadyGoTrade